← Mechanisms of action
ACHE
SINGLE PROTEINHomo sapiens
Preferred name: Acetylcholinesterase ChEMBL ↗
Linked proteins
Drugs acting on this target (35)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| obidoxime (toxogonin) | Activator | experimental | Small molecule | ACHE activator |
| pralidoxime (protopam chloride) | Activator | approved | Small molecule | ACHE activator |
| adenovirus type 4 and type 7 vaccine, live, oral | Immunity, active | approved | Vaccine | ACHE immunity, active |
| adenovirus vaccine, attenuated | Immunity, active | approved | Vaccine | ACHE immunity, active |
| Acotiamide | Inhibitor | experimental | Small molecule | Acetylcholinesterase inhibitor |
| ad-218 | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| ambenonium chloride (mytelase) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| botulinum neurotoxin serotype e | Inhibitor | experimental | Biological | ACHE inhibitor |
| clostridium botulinum toxin | Inhibitor | experimental | Biological | ACHE inhibitor |
| demecarium (humorsol) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| donepezil (aricept) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| echothiophate (phospholine iodide) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| galantamine (reminyl) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| glk-321 | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| hexafluorenium (mylaxen) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| huperzine a | Inhibitor | experimental | Small molecule | Acetylcholinesterase inhibitor |
| imidapril (tanatril) | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| indalapril | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| isoflurophate (floropryl) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| itropride | Inhibitor | experimental | Small molecule | Acetylcholinesterase inhibitor |
| liposomal botulinum toxin a | Inhibitor | experimental | Biological | ACHE inhibitor |
| methanesulfonyl fluoride | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| minaprine | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| monarsen | Inhibitor | experimental | Nucleic acid | ACHE inhibitor |
| neostigmine (bloxiverz) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| octohydroaminoacridine | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| oxiracetam | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| phenserine | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| physostigmine | Inhibitor | marketed | Small molecule | ACHE inhibitor |
| propanidid | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| prx-105 | Inhibitor | experimental | Recombinant protein | ACHE inhibitor |
| pyridostigmine bromide (mestinon) | Inhibitor | approved | Small molecule | ACHE inhibitor |
| sfg-02 | Inhibitor | experimental | Small molecule | ACHE inhibitor |
| tension | Inhibitor | approved | Small molecule | ACHE inhibitor |
| ubretid | Inhibitor | experimental | Small molecule | Acetylcholinesterase inhibitor |